Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 641)
Posted On: 01/07/2021 3:30:46 PM
Post# of 153988
Avatar
Posted By: lorbas
Re: onestepahead #71746
This was the condition of the control group:

None/supplemental oxygen only: 2/402 (0.5);

High flow nasal cannula 110/402 (27.4)

Non-invasive ventilation only: 169/402 (42.0)

Invasive mechanical ventilation: 121/402 (30.1)
Vasopressor support 79/402 (19.7)

Mortality control group: 35.8% (142/397)


However, our severe population in CD-12 was NOT on oxygen delivered through high flow nasal cannula; but I agree that as long as a majority of patients in the trial are from the critical population as specified in the protocol, we should be fine...

" Severe [...] None of the following: Respiratory failure (defined by endotracheal intubation and mechanical ventilation, oxygen delivered by high-flow nasal cannula, noninvasive positive pressure ventilation, or clinical diagnosis of respiratory failure in setting of resource limitations), Septic shock (defined by SBP < 90 mm Hg, or Diastolic BP < 60 mm Hg), Multiple organ dysfunction/failure"













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site